|
CN106727466A
|
|
The derivative composition of Atropurpuran is used to prevent and treat kidney fibrosis
|
|
CN106727522A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used to prevent and treat pancreatic fibrosis
|
|
CN106727565A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used for anti-acute gout
|
|
CN106727564A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used to prevent and treat kidney fibrosis
|
|
CN106727519A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used for anti anoxia
|
|
CN106727594A
|
|
The benzimidazolyl and morpholinyl-derivatives composition of Atropurpuran are used for anti-acute gout
|
|
CN106727595A
|
|
The benzimidazolyl and morpholinyl-derivatives composition of Atropurpuran are used for anti anoxia
|
|
CN106727458A
|
|
The derivative composition of Atropurpuran is used for anti anoxia
|
|
CN106727459A
|
|
The derivative composition of Atropurpuran is used for anti-acute gout
|
|
CN106727520A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used to prevent and treat kidney fibrosis
|
|
CN106727465A
|
|
The derivative composition of Atropurpuran is used to prevent and treat pancreatic fibrosis
|
|
CN106727460A
|
|
The derivative composition of Atropurpuran is used for anti-hepatic fibrosis
|
|
CN106727518A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used for anti-hepatic fibrosis
|
|
CN106727566A
|
|
The piperazinyl of Atropurpuran and two hydroxyethylamine derivative compositions are used for anti-hepatic fibrosis
|
|
CN106727521A
|
|
The imidazole radicals and bischloroethylamines radical derivative composition of Atropurpuran are used for anti-inflammatory
|
|
CN106236747A
|
|
The application in osteosporosis resistant medicament of the Atropurpuran derivative composition
|
|
CN106166152A
|
|
The application in anti-anoxic medicine of the Atropurpuran derivative composition
|
|
CN105920006A
|
|
Applications of composition of Virosaine A piperazinyl derivative and Virosaine A imidazolyl derivative in medicines for resisting hepatic fibrosis
|
|
CN105920014A
|
|
Application of composition of tetrahydropyrrolyl and morpholinyl derivatives of Virosaine A in antibacterial medicines
|
|
CN105920005A
|
|
Application of composition of piperazinyl and imidazolyl derivatives of Virosaine A in acute renal failure resisting medicines
|
